Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HealthSmartRx Smart RxAssist Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Provider-Administered Oncology Drugs
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Asset Publisher
Content with Policies & Guidelines Final Hemophilia Drug Policies .
print
Print
Back
Back
Hemophilia Products - Factor VIII Prior Authorization Program Summary
Policy Number:...
print
Print
Back
Back
Hemophilia Products - Anti-Inhibitor Coagulant Complex: Feiba NF/Feiba VF
Policy...
print
Print
Back
Back
Hemophilia Products - Coagulation Factor XIII A-subunit: Tretten
Policy Number: PH-0338...
Alphanine SD, Alprolix, BeneFIX, Idelvion, Ixinity, Mononine, Profilnine, Rebinyn, and Rixubis
Advate, Adynovate, Afstyla, Eloctate, Hemofil M, Koate DVI, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Obizur, Recombinate, Xyntha/Xyntha Solofuse, Jivi, Esperoct, Altuviiio
print
Print
Back
Back
Hemophilia Products - Factor X: Coagadex
Policy Number: PH-0341
Intravenous
...
print
Print
Back
Back
Hemophilia Products - Factor XIII: Corifact
Policy Number: PH-0342
Intravenous
...
print
Print
Back
Back
Hemophilia Products – Factor VIIa: NovoSeven RT ®; Sevenfact ®
Policy Number: PH-0343
...
print
Print
Back
Back
Hemophilia Products – von Willebrand Factor: Vonvendi®
Policy Number: PH-0344
...
print
Print
Back
Back
Hemophilia Products – Anti-Inhibitor Antibody: Hemlibra ® (emicizumab-kxwh)
Policy...